zoledronic acid has been researched along with Extra-Mammary Paget Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasilakis, AD; Arsos, G; Barmpalios, G; Efstathiadou, Z; Kita, M; Litsas, I; Makrigiannaki, E; Moralidis, E; Panagiotou, A; Papatheodorou, A; Polyzos, SA; Terpos, E; Triantafillidou, E; Zafeiriadou, E | 1 |
| Corretger, X; Fernandez, E; Molina, JJ; Navarro, M; Olver, JM; Ortiz-Perez, S; Sanchez-Dalmau, B | 1 |
1 trial(s) available for zoledronic acid and Extra-Mammary Paget Disease
| Article | Year |
|---|---|
Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Topics: 25-Hydroxyvitamin D 2; Aged; Alkaline Phosphatase; Biomarkers; Body Mass Index; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Calcifediol; Cohort Studies; Collagen Type I; Diphosphonates; Female; Folic Acid; Homocysteine; Humans; Imidazoles; Isoenzymes; Male; Paget Disease, Extramammary; Peptides; Pilot Projects; Time Factors; Vitamin B 12; Zoledronic Acid | 2010 |
1 other study(ies) available for zoledronic acid and Extra-Mammary Paget Disease
| Article | Year |
|---|---|
Two cases of drug-induced orbital inflammatory disease.
Topics: Aged; Bone Density Conservation Agents; Cataract Extraction; Cellulitis; Diagnosis, Differential; Diphosphonates; Female; Humans; Hyaluronoglucosaminidase; Imidazoles; Inflammation; Orbital Diseases; Paget Disease, Extramammary; Zoledronic Acid | 2011 |